Skin intrinsic fluorescence is associated with hemoglobin A 1c and hemoglobin glycation index but not mean blood glucose in children with type 1 diabetes

Diabetes Care

Volumn 34, Issue 8, 2011, Pages 1816-1820

  Felipe, Dania L ^a,b   Hempe, James M ^a,b   Liu, Shuqian ^a,b   Matter, Nate ^c   Maynard, John ^c   Linares, Carmen ^a,b   Chalew, Stuart A ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c VeraLight Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FLUORESCENCE IMAGING; GLUCOSE BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN GLYCATION INDEX; HIGH RISK POPULATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RACE DIFFERENCE; SEX DIFFERENCE; SKIN PIGMENTATION; FLUORESCENCE; METABOLISM; SKIN;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FLUORESCENCE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; SKIN; YOUNG ADULT;

EID: 84862833658     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0049     Document Type: Article

References (25)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-983
2. Ahmed N, Thornalley PJ. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab 2007;9:233-245 (Pubitemid 46502041)
3. Monnier VM, Sell DR, Dai Z, Nemet I, Collard F, Zhang J. The role of the amadori product in the complications of diabetes. Ann N Y Acad Sci 2008;1126:81-88 (Pubitemid 351589314)
4. Bunn HF. Evaluation of glycosylated hemoglobin diabetic patients. Diabetes 1981; 30:613-617
5. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 1986; 35:530-545
6. Service FJ, O'Brien PC. The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial. Diabetologia 2001;44:1215-1220 (Pubitemid 33010497)
7. Monnier VM, Bautista O, Kenny D, et al.; DCCT Skin Collagen Ancillary Study Group. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. Diabetes Control and Complications Trial. Diabetes 1999;48:870-880 (Pubitemid 29153089)
8. Genuth S, Sun W, Cleary P, et al.; DCCT Skin Collagen Ancillary Study Group. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 2005;54:3103-3111 (Pubitemid 43334362)
9. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications 2002; 16:313-320
10. McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 2004; 27:1259-1264 (Pubitemid 38679967)
11. McCarter RJ, Hempe JM, Chalew SA. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial. Diabetes Care 2006; 29:352-355 (Pubitemid 44106517)
12. Conway B, Edmundowicz D, Matter N, Maynard J, Orchard T. Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes. Diabetes Technol Ther 2010;12:339-345
13. Ediger MN, Olson BP, Maynard JD. Non-invasive optical screening for diabetes. J Diabetes Sci Tech 2009;3:776-780
14. Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN. Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C. Diabetes Care 2007;30:1120-1124 (Pubitemid 46684635)
15. Meerwaldt R, Graaff R, Oomen PH, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004;47:1324-1330 (Pubitemid 39093330)
16. Soros AA, Chalew SA, McCarter RJ, Shepard R, Hempe JM. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes 2010;11:455-461
17. Hull EL, Ediger MN, Brown CD, Maynard JD, Johnson RD. Determination of a measure of a glycation end-product or disease state using tissue fluorescence. Patent #7,139,598. 21 November 2006
18. Monnier VM, Vishwanath V, Frank KE, Elmets CA, Dauchot P, Kohn RR. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 1986;314:403-408 (Pubitemid 16161885)
19. Dominiczak MH, Bell J, Cox NH, et al. Increased collagen-linked fluorescence in skin of young patients with type I diabetes mellitus. Diabetes Care 1990;13:468-472 (Pubitemid 20145948)
20. Meerwaldt R, Lutgers HL, Links TP, et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112 (Pubitemid 46052507)
21. Koetsier M, Lutgers HL, de Jonge C, Links TP, Smit AJ, Graaff R. Reference values of skin autofluorescence. Diabetes Technol Ther 2010;12:399-403
22. Dao H Jr, Kazin RA. Gender differences in skin: a review of the literature. Gend Med 2007;4:308-328
23. Noordzij MJ, Lefrandt JD, Graaff R, Smit AJ. Skin autofluorescence and glycemic variability. Diabetes Technol Ther 2010;12:581-585
24. Chalew SA, McCarter RJ, Ory-Ascani J, Hempe JM. Labile A1C is inversely correlated with the hemoglobin glycation index in children with type 1 diabetes. Diabetes Care 2010;33:273-274
25. Service FJ. Correlation between glycemia and glycated hemoglobin. Compr Ther 1990;16:33-40 (Pubitemid 20305318)